Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15121585
Abstract: Recently, two oral-administered peptide pharmaceuticals, semaglutide and octreotide, have been developed and are considered as a breakthrough in peptide and protein drug delivery system development. In 2019, the Food and Drug Administration (FDA) approved an… read more here.
Keywords: oral peptide; development; gastrointestinal permeation; permeation ... See more keywords